Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-29

FDA Approved: NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE — Supplemental Application (Naari Pte Limited)

View source ↗

Summary

FDA approved a supplemental application for a combined oral contraceptive tablet containing norethindrone, ethinyl estradiol, and ferrous fumarate (Naari Pte Li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE TABLET (NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE TABLET)

Snippet

SUPPL AP for NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE TABLET)